Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessAbbott Laboratories Stock Falls 3 percent Following Narrowed Outlook

Abbott Laboratories Stock Falls 3 percent Following Narrowed Outlook

Add to Favorite
Added to Favorite


Abbott Laboratories (NYSE:ABT) surpassed expectations for its first-quarter earnings and revenue, but subsequently narrowed its earnings forecast for the full year 2024, resulting in a more than 3% drop in shares intra-day today. The healthcare company reported earnings of $0.98 per share, which was above the consensus estimate of $0.96. Revenue for the quarter was $9.96 billion, also exceeding expectations of $9.89 billion.
For the upcoming second quarter of 2024, Abbott anticipates earnings per share will be between $1.08 and $1.12, compared to the analyst predictions of $1.12.
For the entire year, Abbott refined its earnings per share forecast to a narrower range of $4.55 to $4.70, tightening from an earlier projection of $4.50 to $4.70, with consensus estimates at $4.62.
In addition, Abbott adjusted its 2024 guidance for organic sales growth, now expecting an increase of between 8.5% and 10.0%, excluding sales related to COVID-19 testing. This update reflects a more optimistic midpoint compared to previous forecasts.

Subscribe to get Latest News Updates

Latest News

You may like more
more